Artelo Biosciences's total assets for Q2 2023 were $16.88M, a decrease of -8.66% from the previous quarter. ARTL total liabilities were $609.00K for the fiscal quarter, a -27.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.